Supernus Pharmaceuticals | SUPN - PE Price to Earnings


Supernus Pharmaceuticals reported $110.38 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Abbott USD 30.71 14.41 Dec/2025
ANI Pharmaceuticals USD 98.67 48.54 Sep/2025
Aurora Cannabis CAD 23.27 0 Sep/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Cara Therapeutics 27.77 117.09 Sep/2021
Corcept Therapeutics USD 41.9 52.28 Dec/2025
Eisai JPY 26.63 0.46 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Novo Nordisk DKK 12.78 0.01 Dec/2025
Pacira USD 29.24 6.15 Sep/2025
Perrigo USD 34.31 15.46 Sep/2025
Pfizer USD 14.48 5.18 Dec/2025
Supernus Pharmaceuticals USD 110.38 71.27 Dec/2025
United Therapeutics USD 17.32 1.62 Dec/2025